AXSM Competitors & Alternatives
Compare Axsome Therapeutics Inc with similar stocks in the same industry
Biotechnology
AXSM
Main Stock$227.72
Tradestie Score
61
Market Cap
$5.92B
Revenue Growth
0.6%
Analyst Upside
+18.7%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$240.50
|
$12.36B | 27.2 | 60 | Compare |
|
EXEL
Exelixis Inc
|
$50.13
|
$11.09B | 16.9 | 63 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$29.29
|
$10.76B | - | 64 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$49.04
|
$10.74B | - | 57 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$51.81
|
$10.53B | 38.3 | 60 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$74.23
|
$10.49B | - | 58 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$66.13
|
$10.22B | - | 55 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$523.69
|
$10.01B | - | 57 | Compare |
|
TECH
Bio-Techne Corp.
|
$43.30
|
$9.33B | 63.9 | 51 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$56.37
|
$8.88B | 166.6 | 56 | Compare |
More AXSM Analysis
Data updated: May 15, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry